JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 2 May 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.00361-07v1
81/13/7111    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, B. J.
Right arrow Articles by Lamb, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, B. J.
Right arrow Articles by Lamb, R. A.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.00361-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles

Benjamin J. Chen, George P. Leser, Eiji Morita, and Robert A. Lamb*

Department of Biochemistry, Molecular Biology and Cell Biology and Howard Hughes Medical Institute, Northwestern University, Evanston, Illinois, 60208-3500 and Department of Biochemistry, University of Utah, Salt Lake City, Utah 84112-5650

* To whom correspondence should be addressed. Email: ralamb{at}northwestern.edu.


   Abstract

For influenza virus we developed an efficient, non-cytotoxic, plasmid-based virus-like particle (VLP) system to reflect authentic virus particles. This system was characterized biochemically by analyzing VLP protein composition, morphologically by electron microscopy, and functionally with a VLP infectivity assay. The VLP system was used to address the identity of the minimal set of viral proteins required for budding. Combinations of viral proteins were expressed in cells and the polypeptide composition of the particles released into the culture media was analyzed. Contrary to the previous findings in which matrix (M1) protein was considered to be the driving force of budding because M1 was found to be released copiously into the culture medium when M1 was expressed by using the vaccinia virus T7 RNA polymerase-driven overexpression system, in our non-cytotoxic VLP system M1 was not released efficiently into the culture medium. Additionally, hemagglutinin (HA), when treated with exogenous neuraminidase (NA) or co-expressed with viral NA, could be released from cells independent of M1. Incorporation of M1 into VLPs required HA expression, although when M1 was omitted from VLPs, particles with a morphology similar to wild type VLPs or viruses were observed. Furthermore, when HA and NA cytoplasmic tail mutants were included in the VLPs, M1 failed to be efficiently incorporated into VLPs consistent with a model in which the glycoproteins control virus budding by sorting to lipid raft microdomains and recruiting the internal viral core components. VLP formation also occurred independent of the function of Vps4 in the multivesicular body pathway as dominant-negative Vps4 proteins failed to inhibit influenza VLP budding.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.